Suppr超能文献

探索用于评估10种癌症干预措施的适应性健康技术评估:来自印度一项试点研究的见解与经验教训。

Exploring adaptive health technology assessment for evaluating 10 cancer interventions: insights and lessons from a pilot study in India.

作者信息

Ghosh Srobana, Pramesh C S, Sengar Manju, Ranganathan Priya, Ruiz Francis, Wadasadawala Tabassum, Nayak Prakash, Thorat Jayashree, Ashok Apurva, Singh Malkeet, Mehndiratta Abha, Nemzoff Cassandra, Shah Hiral Anil

机构信息

Center for Global Development, London, UK

Tata Memorial Centre, Mumbai, Maharashtra, India.

出版信息

BMJ Evid Based Med. 2025 Jan 2. doi: 10.1136/bmjebm-2023-112490.

Abstract

BACKGROUND

Health technology assessment (HTA) is a valuable tool for informing the efficient allocation of resources in healthcare. However, the resource-intensive nature of HTA can limit its application, especially in low-resource settings. Adapting HTA processes by assessing the available international evidence offers a pragmatic approach to provide evidence for decision-making where resources are constrained.

OBJECTIVE

This study piloted an adaptive HTA (aHTA) method to evaluate 10 cancer interventions.

METHODS

We arranged a joint collaboration with the International Decision Support Initiative and the National Cancer Grid in India to form a working group of clinicians and health economists. We conducted a rapid review of HTA reports and economic evaluations for ten prioritised common cancer interventions for breast, lung, and head and neck cancers. We extracted data on cost-effectiveness, conducted a price benchmarking analysis, estimated treatment costs and calculated the treatment's share of the national insurance family allowance. Finally, we determined through qualitative appraisal whether the intervention would likely to be considered cost-effective in the Indian context.

RESULTS

Of the 10 interventions assessed, 9 had sufficient evidence to make determinations on the likely cost-effectiveness. Three were potentially cost-effective (one after a price discount and another by using the generic price), while five were not, and one was only cost-effective in a subgroup. One intervention required a full HTA due to remaining uncertainty. Information on the likely cost-effectiveness, clinical and safety benefits, and treatment costs was consistently found through publicly available evidence. Assessment methods were modified slightly across the 10 interventions, including expanding the data extraction criteria, updating the calculations and broadening the evidence retrieval.

CONCLUSION

The aHTA method is a feasible resource-sensitive alternative to traditional HTA for informing decision-making in resource-constrained settings when ample international data on cost-effectiveness for a given topic is available.

摘要

背景

卫生技术评估(HTA)是指导医疗保健资源有效分配的宝贵工具。然而,HTA资源密集的特性可能会限制其应用,尤其是在资源匮乏的环境中。通过评估现有的国际证据来调整HTA流程,为资源受限情况下的决策提供证据提供了一种务实的方法。

目的

本研究试点了一种适应性卫生技术评估(aHTA)方法,以评估10种癌症干预措施。

方法

我们与国际决策支持倡议组织和印度国家癌症网格组织联合合作,组建了一个由临床医生和卫生经济学家组成的工作组。我们对乳腺癌、肺癌和头颈癌的10种优先常见癌症干预措施的HTA报告和经济评估进行了快速回顾。我们提取了成本效益数据,进行了价格基准分析,估算了治疗成本,并计算了治疗费用在国家保险家庭津贴中的占比。最后,我们通过定性评估确定该干预措施在印度背景下是否可能被认为具有成本效益。

结果

在评估的10种干预措施中,9种有足够的证据来确定其可能的成本效益。3种可能具有成本效益(一种在价格折扣后,另一种使用通用价格),而5种不具有成本效益,1种仅在一个亚组中具有成本效益。由于仍存在不确定性,一种干预措施需要进行全面的卫生技术评估。通过公开可得的证据,始终能找到有关可能成本效益、临床和安全效益以及治疗成本的信息。在10种干预措施中,评估方法略有修改,包括扩大数据提取标准、更新计算方法和拓宽证据检索范围。

结论

当有关于特定主题的充足国际成本效益数据时,aHTA方法是一种可行的、对资源敏感的替代传统HTA的方法,可用于在资源受限环境中为决策提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f826/12213987/39da769c934a/nihms-2045019-f0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验